SAGE Therapeutics Inc
NASDAQ:SAGE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SAGE Therapeutics Inc
NASDAQ:SAGE
|
US |
|
Anup Engineering Ltd
NSE:ANUP
|
IN |
|
SKY Perfect JSAT Holdings Inc
F:SKM
|
JP |
|
W
|
Woodside Petroleum Ltd
F:WOPA
|
AU |
|
S
|
Standard Motor Products Inc
F:SRU
|
US |
|
P
|
Perma-Pipe International Holdings Inc
XBER:MF3
|
US |
|
Nano-X Imaging Ltd
NASDAQ:NNOX
|
IL |
|
T
|
Telenor ASA
SWB:TEQ
|
NO |
|
Engie SA
OTC:ENGQF
|
FR |
|
3
|
3i Group PLC
OTC:TGOPY
|
UK |
|
Genesis AI Corp
F:7JY
|
CA |
|
O
|
Orkla ASA
DUS:OKL
|
NO |
|
N
|
NETGEAR Inc
XMUN:NGJ
|
US |
|
R
|
Robotis Co Ltd
KOSDAQ:108490
|
KR |
|
Power Solutions International Inc
NASDAQ:PSIX
|
US |
|
Meridian Corp
NASDAQ:MRBK
|
US |
|
Lisata Therapeutics Inc
F:8NE
|
US |
|
8
|
8x8 Inc
NASDAQ:EGHT
|
US |
|
M
|
McCormick & Company Inc
BMV:MKCV
|
US |
|
Ubisoft Entertainment SA
OTC:UBSFF
|
FR |
|
Equinox Gold Corp
TSX:EQX
|
CA |
|
A
|
Adaro Energy Indonesia TBK PT
OTC:PADEF
|
ID |
|
E
|
Ems Chemie Holding AG
XMUN:EMC1
|
CH |
|
M
|
MNC Sky Vision Tbk PT
IDX:MSKY
|
ID |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SAGE's stock price target?
Not Available
SAGE does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for SAGE Therapeutics Inc?
Projected CAGR
57%
The compound annual growth rate for Revenue over the next 3 years is 57%.